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The effect of acetyl-L-carnitine on the quantity of the messenger RNA for the subunit I of cytochrome oxidase in the liver mitochondria of hypothy- 
roid rat was measured by Northern blot and solution hybridization. Three hours after pre-treatment of hypothyroid rat with acetyl-L-carnitine, 
the level of the transcript increased strongly. This effect was also obtained when acetyl-L-carnitine was administered to T3 pre-treated hypothyroid 
rats. These results add further evidence to the suggestion that acetyl-L-camitine is able to stimulate mitochondrial transcription under altered meta- 
bolic conditions. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Recent experiments in our laboratory [l] have shown 
that the steady-state concentration of the mRNA for 
the subunit I of cytochrome oxidase (Co1 mRNA) 
undergoes an age-dependent decrease in the rat brain 
and heart. The reduction was reversed by an in vivo pre- 
treatment with acetyl-L-carnitine. The fact that in adult 
rats a similar treatment did not produce any significant 
variation in the mtRNA level supported the hypothesis 
that acetyl-L-carnitine acts by removing some age- 
induced alterations of mitochondrial metabolism which 
affect mtDNA expression. Here, we investigated the ef- 
fect of acetyl-L-carnitine on the steady-state level of 
Co1 mRNA in hypothyroidism, a pathological condi- 
tion where, as well as in aging, impairment of energetic 
metabolism and reduction of the mitochondrial 
transcript level take place [2-91. Pre-treatment of 
hypothyroid rats with acetyl-L-carnitine raised the liver 
Co1 mRNA concentration to that of euthyroid in- 
dividual. Moreover, acetyl-L-carnitine potentiates the 
effect of T3 when both substances are administered in 
vivo. 
2.1. Isolation of mitochondria nd nucleic acid extraction 
Male Fisher 3-month-old rats, housed at a temperature of 22°C and 
fed ad libitum with a standard diet, were used for these studies. Rats 
were made hypothyroid by adding 0.05% (w/v) of propylthiouracyl 
(PTU) to drinking water for 20 days. Tr treatment was performed by 
injecting intraperitoneally 30 &lOO g body weight of 3,3’ ,5-triiodo- 
L-thyronine in 0.9% NaCl/propylenglycol (40:60, v/v). The treat- 
ment was repeated after 24 h and the animals were killed 24 h after the 
second treatment. Acetyl-L-carnitine was administered by injecting 
into the rat 300 mg/kg body weight of acetyl-L-carnitine and killing 
the animals 3 h later. When Ts and acetyl-L-carnitine treatments were 
combined, T3 preceded acetyl-L-carnitine subministration. Rat liver 
mitochondria and mitochondrial nucleic acids were isolated as 
previously reported [l]. DNA and RNA concentrations were deter- 
mined by diphenylamine and orcinol methods, respectively. The con- 
tent of mtDNA co-extracted with mtRNA was determined by a quan- 
titative hybridization procedure where the DNA from an aliquot of 
total mt nucleic acids was digested with the restriction enzyme 
BamHI, run on 1% agarose gel and blot-hydridized to a nick- 
translated fragment of rat mtDNA. Hybridized radioactivity was 
compared with that measured in a series of standard hybridizations 
involving known quantities of purified mtDNA. Details of this pro- 
cedure are described in [l]. 
2.2. Hybridization 
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An mtDNA restriction fragment containing part of the Co1 gene 
was cloned in the vector Bluescribe (Stratagene) and labelled with T7 
RNA polymerase as previously described [ 11. The probe was a frag- 
ment of 855 bp derived from the digestion of EcoRI C with Tug1 [lo]. 
Solution hybridization and RNase treatment were carried out as 
previously reported [ 11. The amount of hybrid was determined by the 
difference between the amount of thrichloroacetic-acid-insoluble 
radioactivity of the samples and that of the controls. The latter con- 
tained the same components of the hybridization mixture except the 
mtRNA. In all experiments, at least two different amounts of total 
mtRNA (10-20 ng) were used; each of them was hybridized to increas- 
ing quantities of radioactive RNA probe. Each experimental point 
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was determined in triplicate. At saturation, the RNase-resistant 
radioactivity was about 5% of the input in the samples and 1% of the 
input in the controls. The statistical significance of differences in 
RNA concentration between treated and untreated animals was deter- 
mined by Student’s t-test. Northern blot hybridization was carried out 
as reported elsewhere [11. 
3. RESULTS 
The measurement of the steady-state level of rat liver 
Co1 mRNA was carried out by a quantitative solution 
hybridization assay in which total mtRNA was 
hybridized to a Co1 riboprobe. The mass of RNA 
hybridized at saturation/mass of total mtRNA was nor- 
malized with respect o the mtDNA co-extracted with 1 
1.18 of total mtRNA. Table I reports the amount of RNA 
hybridized, expressed as the number of CoI mRNA 
molecules per mtDNA molecule in the animals after 
various treatments. It can be seen that hypothyroidism 
causes a decrease of about 50% in the level of Co1 
mRNA. A 3 h pre-treatment of hypothyroid rat with 
a~etyl-L-carnitine is able to raise the level of Co1 
mRNA almost to the level of euthyroid rat. As already 
reported [8], a 48 h pre-treatment of hypothyroid rats 
with T3 is able to bring back the concentration of Co1 
mRNA to that of control rat. When acetyl-L-carnitine 
was administered to T3 treated rat it caused almost a 
doubling of Co1 mRNA content. These observations 
were confirmed also at cellular level: the same amount 
(about 15 pg) of total rat liver RNA was run on a 1.4% 
methylmercuric agarose gel, transferred to a 
nitrocellulose filter and blot-hybridized to a Co1 
Table I 
Effect of various treatments on the level of Co1 mRNA in the liver of 
hypothyroid rats. 
Animals Number of molecules of 
Co1 mRNA/mtDNA molecule 
Control 3.40 i 0.31 
-T3 1.94 * 0.20 
+ T3 3.49 t- 0.44 
+A 2.88 + 0.20 
+T)+A 6.12 * 0.35 
The number of molecules of mtRNA/mtDNA was calculated 
according to the Formula N= A (K/L) where A is the mass (pg) of 
RNA hybridized at saturation with the probe/mass (pg) of total 
mtRNA. K is constant for each mtRNA preparation and comes From 
the ratio of 29.4/mass (ng) of mtDNA coextracted with 1 pg of total 
mtRNA (the factor 29.4 contains constant factors such as the 
molecular weight of the nucleotides and the Avogadro number). L is 
the length of the probe in nucleotides. The amount of the mtDNA co- 
extracted with total mt nucleic acids was determined as described in 
section 2 by at feast 3 independent measurements for each individual. 
The values reported in the Table are the mean $ SD of at least 5 
hybridization experiments repeated each time on 3 mtRNA 
preparations. One individual was used for each RNA preparation. No 
appreciable statistical difference in the hybridization data on the 
single individuals of either group tested was observed. P was always 
less than 2 x IO’, except for the comparison between Tr and acetyl-l- 
carnitine treated rats where it was less than 10-z. A, acetyl-l- 
carnitine. 
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Fig. 1. Content of Co1 mRNA in the total RNA population from 
treated and untreated hypothyroid rat. (A) Northern blot 
hybridization of total RNA isolated from treated and untreated 
hypoth~oid rat. The same amount (15 pg) of total RNA from treated 
and untreated hypothyroid rat was run on a 1.470 methy~mercuric 
agarose gel, transferred to a nitrocellulose filter and hybridized to a 
labelled Co1 riboprobe. RNA transfer and hybridization were carried 
out as reported by Gadaleta et al. [I]. Total cellular RNA was 
extracted from the post-nuclear supernatant by repeated 
phenol/chloroform extractions. (B) Densitometric estimate of the 
hybridj~tion data. The intensity of the bands, measured by 
densitometry (LKB-Ultroscan XL), was referred to the same number 
of liver ceils. Cell number was inferred by measuring the total DNA 
concentration of homogenate. Peak areas were then multiplied for the 
following normalization factors, 1.53, 1.66, 1.05, 1 .OO for 
PTU + Tr + A, PTU + TX, PTU + A and PTU samples, respectively. 
The results are expressed as percentage of increase over hypothyroid 
rat, whose value was set at 100. 
riboprobe. Fig. 1 shows that hypothyroid rats treated 
with acetyl-L-carnitine have a Co1 mRNA content 
similar to that of T, treated rats and that the effect of 
the two substances is additive. 
4. DISCUSSION 
Acetyl-L-carnitine acts by stimulating directly or in- 
directly the energetic metabolism [ 11,12]. Recently we 
found that acetyl-L-carnitine affects also mtRNA 
metabolism [l]: pre-treatment of senescent rats with 
acetyl-L-carnitine raised the level of Co1 mRNA in the 
brain and heart up to that of adult individual. The data 
reported in this paper show that a 3 h pre-treatment 
with acetyl-L-carnitine is able to increase the 
steady-state level of Co1 mRNA of hypothyroid rat 
liver to that of euthyroid and that the effect of acetyl-l- 
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carnitine on Ts-treated hypothyroid individuals is ad- 
ditive to that of T3. These results could be extended to 
all the mtDNA coded RNAs, since it has been shown 
that in rat liver the concentrations of most of the mt 
mRNAs are similar [8] and that they are equally af- 
fected by T3 treatment [9]. The results here reported are 
relevant firstly because they increase the range of 
altered metabolic conditions in which acetyl-L-carnitine 
is effective on mt transcription and secondly because 
they extend the evidence about the relationship between 
the steady-state level of mtRNAs and the cell 
metabolism [8-10, 13-221. The real mechanism of the 
acetyl-L-carnitine action on the mtDNA transcription 
both in senescence and in hypothyroidism remains to be 
understood. However, it could be hypothesized that in 
both cases acetyl-L-carnitine might be able to re- 
establish the correct structure and function of 
mitochondrial membranes which appear to be altered in 
these two conditions [23-291. Some recent findings in 
our laboratory confirm this hypothesis: acetyl-l- 
carnitine treatment normalizes age-induced alterations 
in the lipid composition of rat plasma [30] and of brain 
and heart rat mitochondria (Ruggiero and Gadaleta, in 
preparation). Mitochondrial membrane permeability 
could be relevant for mtDNA transcription influencing 
aspects such as optimal mitochondrial concentration of 
ATP and/or monovalent and divalent cations [31], im- 
port into mitochondria of RNA polymerase and of 
other nuclear DNA encoded proteins required for 
mtRNA synthesis [32] and processing [33]. 
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